Recent AIM News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/15/2024 09:59:47 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/15/2024 09:33:10 PM
- AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/15/2024 12:29:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:40:29 PM
- Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/14/2024 09:25:58 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2024 08:21:36 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/08/2024 10:27:06 PM
- Form DEFC14A - Definitive proxy statement, contested solicitations • Edgar (US Regulatory) • 11/06/2024 02:02:05 PM
- AIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and Webcast • GlobeNewswire Inc. • 11/06/2024 02:00:00 PM
- AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders • Business Wire • 11/04/2024 01:00:00 PM
- Form DEFC14A - Definitive proxy statement, contested solicitations • Edgar (US Regulatory) • 11/04/2024 12:00:16 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 10/30/2024 08:50:29 PM
- Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise • Edgar (US Regulatory) • 10/30/2024 04:53:26 PM
- Form PREC14A - Preliminary proxy statements, contested solicitations • Edgar (US Regulatory) • 10/18/2024 08:34:17 PM
- Form PREC14A - Preliminary proxy statements, contested solicitations • Edgar (US Regulatory) • 10/15/2024 08:33:31 PM
- AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC • GlobeNewswire Inc. • 10/09/2024 01:00:00 PM
- AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis • GlobeNewswire Inc. • 10/03/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 07:55:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/01/2024 05:12:28 PM
- AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering • GlobeNewswire Inc. • 09/30/2024 01:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/30/2024 12:22:43 PM
- AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment • GlobeNewswire Inc. • 09/27/2024 12:00:00 PM
- AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer • GlobeNewswire Inc. • 09/19/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 04:05:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 07:45:11 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM